|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's range||128.33 - 130.97|
|52-week range||96.31 - 132.39|
|Beta (5Y monthly)||0.81|
|PE ratio (TTM)||48.26|
|Earnings date||24 Aug 2021|
|Forward dividend & yield||2.52 (1.96%)|
|Ex-dividend date||24 Jun 2021|
|1y target est||140.46|
The medical device company's Hugo robotic-assisted surgery (RAS) system may end up playing a significant role in its growth.
Medtronic's (MDT) newly-launched Prevail DCB demonstrates impressive safety and drug deliverability, utilizing a rapid absorption drug to treat patients with coronary artery disease.
Recent integration of Medtronic's (MDT) Hugo RAS System at UC CHRISTUS is intended to support the teaching institution's new robotic surgery program.